Wells Fargo lifts Edwards Lifesciences target after Q3 beat
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
Wells Fargo raised its Edwards Lifesciences price target to Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context